A Managed Healthcare Executive’s cancer management survey revealed support for the selected use of complementary and alternative medicine. Where do things stand in what some consider a promising treatment area?
If it's true that a picture is worth a thousand words, the same can be said for numbers. For any healthcare executive, a look at relevant statistics can be revealing. Here are some of the top stats to know.
In this era of precision oncology and targeted therapies for cancer, it’s even more important to include different populations when doing clinical trials. Here are three effective strategies.
Gwen Nichols, MD, chief medical officer of the Leukemia & Lymphoma Society, offers a quick overview of current developments as well as a look forward.
What does team-based cancer care done right look like? Here are two real-word models worth emulating.
As a healthcare executive you may not conduct research or administer medications, but you can still play an important role in helping improve treatment for lymphoma as well as other blood cancers. Here are five areas in which you can make an impact.
Ron Barkley, president of the Cancer Center Business Development Group, which consults with oncology providers on value-based care arrangements, shares tips.